Cargando…

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary aspergillosis have raised concerns about it worsening the disease course of COVID-19 and increasing mortality. Additionally, the firs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koehler, Philipp, Bassetti, Matteo, Chakrabarti, Arunaloke, Chen, Sharon C A, Colombo, Arnaldo Lopes, Hoenigl, Martin, Klimko, Nikolay, Lass-Flörl, Cornelia, Oladele, Rita O, Vinh, Donald C, Zhu, Li-Ping, Böll, Boris, Brüggemann, Roger, Gangneux, Jean-Pierre, Perfect, John R, Patterson, Thomas F, Persigehl, Thorsten, Meis, Jacques F, Ostrosky-Zeichner, Luis, White, P Lewis, Verweij, Paul E, Cornely, Oliver A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833078/ https://www.ncbi.nlm.nih.gov/pubmed/33333012 http://dx.doi.org/10.1016/S1473-3099(20)30847-1

Ejemplares similares

618. The current state of laboratory mycology in Asia/Pacific: a survey from the EuropeanConfederation of Medical Mycology (ECMM) and International Society for Human andAnimal Mycology (ISHAM)
por: Salmanton-Garcia, Jon, et al.
Publicado: (2023)

International Society for Human and Animal Mycology (ISHAM)—New Initiatives
por: Chakrabarti, Arunaloke, et al.
Publicado: (2020)

Diagnosing COVID-19-associated pulmonary aspergillosis
por: Verweij, Paul E, et al.
Publicado: (2020)

Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement
por: Jenks, Jeffrey D., et al.
Publicado: (2020)

617. Laboratory capacities to diagnose and treat Invasive Fungal Infections in Europe: results from an ECMM survey
por: Salmanton-Garcia, Jon, et al.
Publicado: (2023)

753. Guideline Adherence Predicts Outcomes of Candidemia in Europe: Results from the ECMM Candida III Multinational European study
por: Hoenigl, Martin, et al.
Publicado: (2022)

A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC
por: de Hoog, Sybren, et al.
Publicado: (2023)

9th Trends in Medical Mycology Held on 11–14 October 2019, Nice, France, Organized under the Auspices of EORTC-IDG and ECMM
por: Gangneux, Jean-Pierre, et al.
Publicado: (2019)

EQUAL Score Scedosporiosis/Lomentosporiosis 2021: a European Confederation of Medical Mycology (ECMM) tool to quantify guideline adherence
por: Stemler, Jannik, et al.
Publicado: (2021)

10th Trends in Medical Mycology Held on 8 to 11 October 2021, Aberdeen, Scotland, Organized by the European Confederation of Medical Mycology (ECMM)
por: Cornely, Oliver A., et al.
Publicado: (2021)

Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study
por: Egger, Matthias, et al.
Publicado: (2023)

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
por: Hoenigl, Martin, et al.
Publicado: (2022)

Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2022)

Dislocation of the Astragalus: Case in the Practice of Dr. Isham
por: Strout,
Publicado: (1874)

Intro special issue MMCR session ISHAM
por: Warris, Adilia
Publicado: (2023)

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
por: Arastehfar, Amir, et al.
Publicado: (2020)

EQUAL Trichosporon Score 2022: an ECMM score to measure QUALity of the clinical management of invasive Trichosporon infections
por: Sprute, Rosanne, et al.
Publicado: (2022)

Immunological response to COVID-19 and its role as a predisposing factor in invasive aspergillosis
por: Tavakoli, Mahin, et al.
Publicado: (2020)

Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-fumigatus Aspergillus spp.
por: Stemler, Jannik, et al.
Publicado: (2023)

Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
por: Perfect, John R., et al.
Publicado: (2018)

COVID‐19 associated pulmonary aspergillosis
por: Koehler, Philipp, et al.
Publicado: (2020)

Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management
por: Rudramurthy, Shivaprakash M., et al.
Publicado: (2019)

824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis
por: Marty, Francisco M., et al.
Publicado: (2014)

Liposomal amphotericin B—the past
por: Brüggemann, R J, et al.
Publicado: (2022)

Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature
por: Mayr, A, et al.
Publicado: (2011)

Clinical prediction rules for invasive candidiasis in the ICU: ready for prime time?
por: Ostrosky-Zeichner, Luis
Publicado: (2011)

An Overview of Systematic Reviews of Polymerase Chain Reaction (PCR) for the Diagnosis of Invasive Aspergillosis in Immunocompromised People: A Report of the Fungal PCR Initiative (FPCRI)—An ISHAM Working Group
por: Cruciani, Mario, et al.
Publicado: (2023)

EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19
por: Salmanton-García, Jon, et al.
Publicado: (2021)

Hypoxia Decreases Diagnostic Biomarkers for Aspergillosis In Vitro
por: Maurer, Elisabeth, et al.
Publicado: (2019)

Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope(®) registry
por: Sal, Ertan, et al.
Publicado: (2022)

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
por: Hoenigl, Martin, et al.
Publicado: (2021)

Immune Parameters for Diagnosis and Treatment Monitoring in Invasive Mold Infection
por: Jenks, Jeffrey D., et al.
Publicado: (2019)

Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance
por: Ellsworth, Misti, et al.
Publicado: (2020)

Investigational Agents for the Treatment of Resistant Yeasts and Molds
por: Seiler, Garret T., et al.
Publicado: (2021)

COVID-19-Associated Pulmonary Aspergillosis Isolates Are Genomically Diverse but Similar to Each Other in Their Responses to Infection-Relevant Stresses
por: Mead, Matthew E., et al.
Publicado: (2023)

P1607: EPICOVIDEHA KIDS: A READY TO USE PLATFORM FOR EPIDEMIOLOGICAL STUDIES IN PEDIATRIC HEMATOLOGICAL PATIENTS WITH COVID-19
por: Salmanton-García, J., et al.
Publicado: (2022)

HIV and fungal priority pathogens
por: Sati, Hatim, et al.
Publicado: (2023)

Estimation of the Burden of Chronic and Allergic Pulmonary Aspergillosis in India
por: Agarwal, Ritesh, et al.
Publicado: (2014)

2268. Clinical Implications of Azole-Resistant vs. Azole-Susceptible Invasive Aspergillosis in Hematological Malignancy (CLARITY): A Multicenter Study
por: Seidel, Danila, et al.
Publicado: (2019)

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses
por: Thompson, George R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2fi4l44m35unq3d5bc5ec2r37i